Paper - WANFANG MED ONLINE

You Position: Home > Paper

Imaging progress in the evaluation of targeted therapy and immunotherapy for colorectal cancer

( views:316, downloads:360 )

Author:: No author available

Journal Title:: Chinese Journal of Radiology

Issue:: 11

DOI:: 10.3760/cma.j.cn112149-20200222-00229

Key Word:: 结直肠肿瘤;分子显像;靶向治疗;免疫治疗

Abstract：结直肠癌是常见的恶性肿瘤，靶向治疗及免疫治疗已经成为重要的治疗手段，并取得了很好的疗效。常规影像学可以观察肿瘤治疗前后的大小、形态、密度或信号强度、血流等变化，分子影像学可以在细胞和分子水平上监测治疗进程和评价疗效，并能够为患者提供个体化的治疗方案。随着显像评估方法不断改进，分子探针不断研发，多模态诊疗一体化及纳米复合物逐步兴起，影像学为结直肠癌的诊断、监测、疗效评估及预后判定提供了更加全面的方法，具有重要的临床价值及应用前景。

Reference

[1]Levi, Jelena,Lam, Tina,Goth, Samuel R.,etc.Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-PD-1 Therapy[J].2019,79(13).
[2]Maute, Roy L.,Gordon, Sydney R.,Mayer, Aaron T.,etc.Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging[J].2015,112(47).
[3]Larimer, Benjamin M.,Wehrenberg-Klee, Eric,Caraballo, Alexander,etc.Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy[J].2016,57(10).
[4]Keita, Saito,Shingo, Matsumoto,Yoichi, Takakusagi,etc.13C-MR Spectroscopic Imaging with Hyperpolarized [1-13C]pyruvate Detects Early Response to Radiotherapy in SCC Tumors and HT-29 Tumors.[J].2015,21(22).
[5]Makela Ashley V.,Foster Paula J..Imaging macrophage distribution and density in mammary tumors and lung metastases using fluorine-19 MRI cell tracking[J].2018,80(3).
[6]Woff, Erwin,Hendlisz, Alain,Garcia, Camilo,etc.Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer[J].2016,43(10).
[7]Dohan, Anthony,Gallix, Benoit,Guiu, Boris,etc.Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab[J].2020,69(3).
[8]Radoul, Marina,Chaumeil, Myriam M.,Eriksson, Pia,etc.MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide: Metabolic Changes Are Associated with Enhanced Survival[J].2016,15(5).
[9]Ahrens, Eric T.,O'Hanlon, Charles F.,Schirda, Claudiu,etc.Clinical Cell Therapy Imaging Using a Perfluorocarbon Tracer and Fluorine-19 MRI[J].2014,72(6).
[10]M W,Huellner.Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer.[J].2012,12.
[11]Herbst Roy S.,Soria Jean-Charles,Kowanetz Marcin,etc.Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients[J].2014,515(7528).
[12]Shoujun Zhu,Qinglai Yang,Alexander L. Antaris,etc.Molecular imaging of biological systems with a clickable dye in the broad 800- to 1,700-nm near-infrared window[J].2017,114(5).
[13]E. J. van Helden,S. G. Elias,S. L. Gerritse,etc.[ 89 Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer[J].2020,47(4).
[14]Mayer, Aaron T.,Natarajan, Arutselvan,Gordon, Sydney R.,etc.Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging[J].2017,58(4).
[15]Ceelen,W.,VanDeWiele,C.,Mertens,J.,etc.Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases[J].2012,106(12).
[16]Khurana Aman,Chapelin Fanny,Xu Hongyan,etc.Visualization of macrophage recruitment in head and neck carcinoma model using fluorine‐19 magnetic resonance imaging[J].2018,79(4).
[17]Matsumoto,S.,Saito,K.,Takakusagi,Y.,etc.In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: Longitudinal assessment to identify transient vascular renormalization[J].2014,21(8).
[18]Hesketh, Richard L.,Wang, Jiazheng,Wright, Alan J.,etc.Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death-Dependent Changes in Glycolysis[J].2019,79(14).
[19]Goh,V.,Glynne-Jones,R..Perfusion CT imaging of colorectal cancer[J].2014,87(1034).
[20]Koh, Frederick H. X.,Tan, Ker-Kan,Teo, Lynette L. S.,etc.Prospective comparison between magnetic resonance imaging and computed tomography in colorectal cancer staging[J].2018,88(6).
[21]Yeo-Eun Kim,Bio Joo,Mi-Suk Park,etc.Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial.[J].2016,(4).
[22]Yang Du,Xiaolong Liang,Yuan Li,etc.Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments[J].2018,414.
[23]Marin,D.,Boll,D.T.,Mileto,A.,etc.State of the art: Dual-energy CT of the abdomen[J].2014,271(2).
[24]Heskamp, Sandra,Hobo, Willemijn,Molkenboer-Kuenen, Janneke D. M.,etc.Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies[J].2015,75(14).
[25]Vincenza, Granata,Roberta, Fusco,Orlando, Catalano,etc.Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.[J].2015,10.
[26]Fan Yong,Wang Peiyuan,Lu Yiqing,etc.Lifetime-engineered NIR-II nanoparticles unlock multiplexed in vivo imaging[J].2018,13(10).
[27]Passardi, Alessandro,Canale, Matteo,Valgiusti, Martina,etc.Immune Checkpoints as a Target for Colorectal Cancer Treatment[J].2017,18(6).
[28]Camilla,Mattiuzzi,Fabian,Sanchis-Gomar,Giuseppe,Lippi.Concise update on colorectal cancer epidemiology.[J].2019,7(21).
[29]Zhong Yeteng,Ma Zhuoran,Wang Feifei,etc.In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles[J].2019,37(11).
[30]Wu, Jingjun,Lv, Yue,Wang, Nan,etc.The value of single-source dual-energy CT imaging for discriminating microsatellite instability from microsatellite stability human colorectal cancer[J].2019,29(7).
[31]Yang Du,Xiaolong Liang,Yuan Li.EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer[J].2018,10(35).
[32]Sarah J. Nelson,John Kurhanewicz,Daniel B. Vigneron,etc.Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-~(13)C]Pyruvate[J].2013,5(197).
[33]Froelich, Matthias F.,Heinemann, Volker,Sommer, Wieland H.,etc.CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial[J].2018,28(12).
[34]Al B, Benson,Alan P, Venook,Lynette, Cederquist,etc.Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.[J].2017,15(3).
[35]Pagès F,Galon J,Dieu-Nosjean M-C,etc.Immune infiltration in human tumors: a prognostic factor that should not be ignored[J].2009,29(8).